Top API Manufacturer Expands Innovation and Global Supply Capabilities in Pharmaceutical Development
Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...
Pharmaceutical Executive: What elements is the conversation about bringing pharma manufacturing home missing? Charlie Lyon: ...
Track Auro Laboratories share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit ...
Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.
Building on Dalton's successful feasibility and earlier scale-up activities supporting preclinical material production, as referenced in the Company press releases dated May 26 and November 20, 2025, ...
Former Cipla CEO to lead the next phase of transformation and growth at Cohance and help build India’s leading technology-driven CDMO platform ...
Google unveiled Deep Research and Deep Research Max, new Gemini 3.1 Pro-powered AI agents that combine web search, proprietary enterprise data, MCP integrations, and native charts to automate ...
Amines are a functional group characterized by the presence of a nitrogen atom bonded to one or more alkyl or aryl (aromatic ...
We tested both on writing, coding, research, and video. See which one fits your workflow, budget, and use case.
The selective conversion of alkenes into alcohols is a cornerstone of modern chemical synthesis, underpinning the production ...
Sulfones, characterised by a divalent sulphur atom doubly bonded to oxygen and linked to two carbon centres, are indispensable scaffolds in pharmaceuticals, agrochemicals and advanced materials.
Optimized additive selection could help yeast-based cell-free protein expression systems fulfill their potential at commercial scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results